Press Releases

Updates from companies that share news on HearingTracker

Page 22 of 42

Regeneron to Acquire Decibel Therapeutics and Its Investigational DB-OTO Gene Therapy for Hearing Loss

Regeneron to Acquire Decibel Therapeutics and Its Investigational DB-OTO Gene Therapy for Hearing Loss

Regeneron Pharmaceuticals plans to acquire Decibel Therapeutics in a deal valued at around $109 million based on the amount payable at closing, and a total equity value of up to $213 million if the CVR milestones are achieved. The companies have collaborated since 2017 and are developing gene therapy programs, with DB-OTO in a Phase 1/2 clinical trial as a potential solution for congenital hearing loss caused by otoferlin gene mutations.

Staff
Starkey Wins 2023 Top Workplaces Culture Excellence Awards

Starkey Wins 2023 Top Workplaces Culture Excellence Awards

Starkey received recognition across all five categories of the 2023 Top Workplaces Culture Excellence awards for outstanding achievements in Work-Life Flexibility, Purpose and Values, Compensation and Benefits, Leadership, and Innovation.

Staff